Bakhu Holdings, Corp. Stock

Equities

BKUH

US0575862083

Healthcare Facilities & Services

Delayed OTC Markets 09:30:00 2024-06-04 am EDT 5-day change 1st Jan Change
0.25 USD 0.00% Intraday chart for Bakhu Holdings, Corp. 0.00% +150.00%
Sales 2022 - Sales 2023 - Capitalization 298M
Net income 2022 -20M Net income 2023 -10M EV / Sales 2022 -
Net Debt 2022 6.36M Net Debt 2023 6.74M EV / Sales 2023 -
P/E ratio 2022
-15.8 x
P/E ratio 2023
-28.9 x
Employees 2
Yield 2022 *
-
Yield 2023
-
Free-Float 33.87%
More Fundamentals * Assessed data
Dynamic Chart
1 week
0.24
Extreme 0.24
0.25
1 month
0.11
Extreme 0.11
0.25
Current year
0.11
Extreme 0.11
0.25
1 year
0.01
Extreme 0.005
1.10
3 years
0.00
Extreme 0.0011
7.99
5 years
0.00
Extreme 0.0011
14.00
10 years
0.00
Extreme 0.0011
188.00
More quotes
Date Price Change Volume
24-06-04 0.25 0.00% 4,492
24-06-03 0.25 0.00% 5,220
24-05-31 0.25 0.00% 3,008
24-05-30 0.25 0.00% 2,500
24-05-29 0.25 +25.00% 8,000

Delayed Quote OTC Markets, June 04, 2024 at 09:30 am EDT

More quotes
Bakhu Holdings, Corp. is a development-stage company. The Company hold a license from Cell Science to plant cell-extraction and replication technology and related equipment, processes, and formulations (the Licensed Science), to produce, manufacture, and sell cannabis-related byproducts - sometimes referred to as cannabinoids in North America, Central America, and the Caribbean for medical, food additive, and recreational uses. The Company is focused on testing and commercializing cannabis plant cell-extraction and replication technologies under a technology license granted by Cell Science. It also intends to sublicense the Licensed Science to third party sub-licensees. The Company has not generated any revenue.
More about the company